Competition Commission has cleared the proposed purchase of 2% stake in handset maker Micromax by Madison India Opportunities Trust Fund (MIOTF) besides three other deals involving different companies.
In a tweet, the watchdog said it has approved “acquisition of equity stake in Micromax Informatics Limited by Madison India Opportunities Trust Fund”. MIOTF is registered with capital market regulator as an Alternative Investment Fund. Separately, Competition Commission of India (CCI) has given its nod to ICU Medical Inc buying drug major Pfizer’s hospira infusion systems business. Post deal, Pfizer would own around 16.6% of ICU Medical, as per a release issued by the drug maker in October.
In another tweet, CCI said its has cleared “acquisition of Pfizer Inc’s Hospira Infusion Systems business by ICHOSPIRA U Medical Inc”. Pfizer has good presence in India. ICU Medical is into development, manufacture and sale of innovative medical devices. The fair trade regulator has also given the green signal for the proposed joint venture between TDK Corp and Toshiba Corp. According to a filing by the companies to the watchdog, Toshiba would hold 25% shares in the joint venture and the remaining 75% would be with TDK.
The joint venture named TDK Automotive Technologies Corporation, would engage in the development, manufacture and sales of automotive inverters for hybrid vehicles, plug-in hybrid vehicles and electric vehicles, a Toshiba press release had said. Both companies have India presence. The acquisition of stake in Gestamp Automocion S A by Mitsui & Co has also been cleared by the regulator. “CCI India approves acquisition of 12.525% stake in Gestamp Automocion S A by Mitsui & Co Ltd,” another tweet said. Mitsui, through its subsidiaries, is mainly engaged in the field of import and export related transactions and various manufacturing and sales operations with Indian companies. Gestamp Automocion S.A is into automotive components and assemblies. Both entities have presence in India.